Supayang P Voravuthikunchai Selected Research

rhodomyrtone

5/2021	Rhodomyrtone Accumulates in Bacterial Cell Wall and Cell Membrane and Inhibits the Synthesis of Multiple Cellular Macromolecules in Epidemic Methicillin-Resistant Staphylococcus aureus.
1/2021	Rhodomyrtone as a New Natural Antibiotic Isolated from Rhodomyrtus tomentosa Leaf Extract: A Clinical Application in the Management of Acne Vulgaris.
11/2020	Rhodomyrtus tomentosa Leaf Extract and Rhodomyrtone Combat Streptococcus pneumoniae Biofilm and Inhibit Invasiveness to Human Lung Epithelial and Enhance Pneumococcal Phagocytosis by Macrophage.
1/2018	The small molecule rhodomyrtone suppresses TNF-α and IL-17A-induced keratinocyte inflammatory responses: A potential new therapeutic for psoriasis.
2/2016	Rhodomyrtone as a potential anti-proliferative and apoptosis inducing agent in HaCaT keratinocyte cells.
2/2011	Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Supayang P Voravuthikunchai Research Topics

Disease

8	Infections 08/2021 - 02/2011
3	Wounds and Injuries (Trauma) 09/2022 - 02/2016
2	Inflammation (Inflammations) 01/2018 - 01/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018 - 02/2016
2	Tuberculosis (Tuberculoses) 01/2018 - 04/2016
1	Acne Vulgaris 01/2021
1	Pneumococcal Infections 11/2020
1	Ventilator-Associated Pneumonia 01/2020
1	Cross Infection (Nosocomial Infection) 01/2020
1	Hyperplasia 01/2018
1	Skin Diseases (Skin Disease) 01/2018

Drug/Important Bio-Agent (IBA)

6	rhodomyrtoneIBA 05/2021 - 02/2011
4	Anti-Bacterial Agents (Antibiotics)IBA 06/2021 - 01/2020
3	CytokinesIBA 01/2018 - 04/2016
2	SilverIBA 09/2022 - 01/2020
2	Carbapenems (Carbapenem Antibiotics)IBA 08/2021 - 06/2021
2	Pharmaceutical PreparationsIBA 05/2021 - 05/2014
2	Polysaccharides (Glycans)IBA 01/2021 - 01/2020
2	Capsules (Microcapsules)IBA 11/2020 - 01/2020
2	PhytochemicalsIBA 01/2018 - 02/2016
2	Macrophage Migration-Inhibitory FactorsIBA 01/2018 - 04/2016
1	Hypromellose DerivativesIBA 09/2022
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 09/2022
1	Polyvinyl AlcoholIBA 09/2022
1	SodiumIBA 09/2022
1	Free Radical ScavengersIBA 09/2022
1	xanthan gum (xanthan)FDA LinkGeneric 09/2022
1	AminoglycosidesIBA 08/2021
1	Anti-Infective Agents (Microbicides)IBA 08/2021
1	Meropenem (Merrem)FDA LinkGeneric 08/2021
1	Colistin (Coly-Mycin)FDA Link 06/2021
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 11/2020
1	Nylons (Nylon)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Imiquimod (Aldara)FDA LinkGeneric 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	SolutionsIBA 01/2017
1	Synthetic DrugsIBA 02/2016

Therapy/Procedure

2	Therapeutics 08/2021 - 01/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2020